Pacira BioSciences, Inc. (PCRX)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	745,130	689,969	632,214	543,113	509,994	447,255	429,324	376,114	498,334	533,411	526,210	667,018	866,048	822,352	792,579	720,247	651,623	658,520	455,823	431,594
Total current liabilities	US$ in thousands	309,920	306,401	92,690	93,444	97,383	93,661	108,912	98,698	147,774	131,526	133,179	305,073	521,118	225,788	228,693	232,084	253,328	86,272	70,583	80,313
Current ratio		2.40	2.25	6.82	5.81	5.24	4.78	3.94	3.81	3.37	4.06	3.95	2.19	1.66	3.64	3.47	3.10	2.57	7.63	6.46	5.37

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $745,130K ÷ $309,920K
= 2.40

The current ratio for Pacira BioSciences, Inc. experienced fluctuation over the analyzed period, ranging from a low of 1.66 to a high of 7.63. Generally, a current ratio above 1 indicates that the company has more current assets than current liabilities, which is considered a positive sign of liquidity.

The ratio peaked at 7.63 on September 30, 2020, indicating a strong ability to cover short-term obligations with current assets. However, it decreased significantly by the end of 2021 to 1.66, which may raise some concerns about the company's liquidity position.

Subsequently, the current ratio improved gradually, reaching its highest point at 6.82 on June 30, 2024, before declining to 2.40 by the end of December 2024. This fluctuation suggests that Pacira BioSciences, Inc. may have experienced changes in its current assets and liabilities composition during this period.

Overall, while the current ratio has shown some variability, it generally stayed above 1, indicating that the company has been able to meet its short-term obligations throughout the analyzed period.